IRAK-IN-6, formerly known as IRAK inhibitor 6, is an interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor. IRAK-4 is reported to be essential for the activation of the intracellular signalling cascades including NFКB and MAPK pathways, which are critical for the production of inflammatory cytokines.
Physicochemical Properties
| Molecular Formula | C20H20N4O3S |
| Molecular Weight | 396.46 |
| Exact Mass | 396.125 |
| CAS # | 1042672-97-8 |
| Related CAS # | 1042672-97-8; |
| PubChem CID | 44449392 |
| Appearance | Light brown to brown solid powder |
| Density | 1.3±0.1 g/cm3 |
| Index of Refraction | 1.652 |
| LogP | 1.59 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 28 |
| Complexity | 520 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | JQSRUVXPODZKAF-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C20H20N4O3S/c1-26-18-11-15(24-7-9-27-10-8-24)4-5-16(18)22-19(25)17-13-28-20(23-17)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,22,25) |
| Chemical Name | N-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide |
| Synonyms | IRAK-IN-6 IRAK IN 6 IRAKIN6 IRAK inhibitor 6 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | IRAK inhibitor 6 is the most potent of these drugs tested; potency additive, IRAK inhibitor 6 considerably improves potency against IRAK-4 [1]. |
| References |
[1]. IRAK-4 inhibitors. Part 1: a series of amides. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3211-4. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~8.33 mg/mL (~21.01 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.83 mg/mL (2.09 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 8.3 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 + to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5223 mL | 12.6116 mL | 25.2232 mL | |
| 5 mM | 0.5045 mL | 2.5223 mL | 5.0446 mL | |
| 10 mM | 0.2522 mL | 1.2612 mL | 2.5223 mL |